Straumann Holding AG (STMN) - Product Pipeline Analysis, 2022 Update

Summary

Straumann Holding AG (Straumann) develops, manufactures, and markets tooth replacement and orthodontic solutions. The company's products include dental implants, instruments, digital equipment, CAD/ CAM prosthetics, dental biomaterials, software, and clear aligners for application in tooth replacement, restoration, and prevention of tooth loss. It also provides training, support, and other services to dental practitioners, clinics, and laboratories. Straumann offers products and solutions for both conventional treatment and digital workflows including guided surgery and intra-oral scanning. The company distributes its products, solutions, and services directly and also through a network of partners in Europe, the Middle East and Africa, North America; Asia Pacific; and Latin America. Straumann is headquartered in Basel, Switzerland.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Straumann Holding AG
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Straumann Holding AG Company Overview
Straumann Holding AG Company Snapshot
Straumann Holding AG Pipeline Products and Ongoing Clinical Trials Overview
Straumann Holding AG – Pipeline Analysis Overview
Business Description
Straumann Holding AG - Key Facts
Straumann Holding AG - Major Products and Services
Straumann Holding AG Pipeline Products by Development Stage
Straumann Holding AG Ongoing Clinical Trials by Trial Status
Straumann Holding AG Pipeline Products Overview
Angulated Solution
Angulated Solution Product Overview
ClearCorrect System
ClearCorrect System Product Overview
ClearQuartz
ClearQuartz Product Overview
ClearQuartz Clinical Trial
Colored Prosthetics
Colored Prosthetics Product Overview
Enhanced Bone Graft
Enhanced Bone Graft Product Overview
Grand Morse System
Grand Morse System Product Overview
Grand Morse System Clinical Trial
Integrated Workflow
Integrated Workflow Product Overview
Neodent Zi
Neodent Zi Product Overview
Next Generation Biomaterials
Next Generation Biomaterials Product Overview
Next Generation Fixture System
Next Generation Fixture System Product Overview
NUVO IF Implant System
NUVO IF Implant System Product Overview
NUVO IF Implant System Clinical Trial
NUVO Instrument Kit Case
NUVO Instrument Kit Case Product Overview
Single-Use Instrument
Single-Use Instrument Product Overview
Soft Tissue Control Implant
Soft Tissue Control Implant Product Overview
Straumann TLX Implant System
Straumann TLX Implant System Product Overview
Variobase Extensions
Variobase Extensions Product Overview
Virtuo Harmony
Virtuo Harmony Product Overview
Straumann Holding AG - Key Competitors
Straumann Holding AG - Key Employees
Straumann Holding AG - Key Employee Biographies
Straumann Holding AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Straumann Holding AG, Recent Developments
May 21, 2022: Straumann Malaysia, part of The Straumann Group, a leading implantology company, intends to provide 3,000 dental implant packages to the Ministry of Health Malaysia as part of MoU
Feb 15, 2022: Straumann Group reports revenue exceeding CHF 2 billion
Feb 04, 2022: Straumann Group announces invitation for 2021 full-year financial results webcast
Dec 16, 2021: Straumann Group presents evolved strategy to achieve its long-term revenue ambition of CHF 5 billion
Oct 18, 2021: Straumann Group 2021 third-quarter financial results webcast invitation
Sep 08, 2021: Straumann Group and Aspen Dental Management partner to offer dental implants and prosthetic solutions to over 1,000 locations across the U.S.
Aug 16, 2021: Sage Dental to offer AI-powered remote orthodontic treatment monitoring, digital intraoral scanning for esthetic dentistry in partnership with Straumann Group
Jul 29, 2021: Invitation: Straumann Group 2021 half-year financial results webcast
Jul 15, 2021: Christian Ullrich joins Straumann Group’s Executive Management Board as the new Group Chief Information Officer
Jun 01, 2021: ClearCorrect announces faster manufacturing turnaround time for clear aligners
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Straumann Holding AG Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Straumann Holding AG Pipeline Products by Equipment Type
Table 3: Straumann Holding AG Pipeline Products by Indication
Table 4: Straumann Holding AG, Key Facts
Table 5: Straumann Holding AG, Major Products and Services
Table 6: Straumann Holding AG Number of Pipeline Products by Development Stage
Table 7: Straumann Holding AG Pipeline Products Summary by Development Stage
Table 8: Straumann Holding AG Ongoing Clinical Trials by Trial Status
Table 9: Straumann Holding AG Ongoing Clinical Trials Summary
Table 10: Angulated Solution - Product Status
Table 11: Angulated Solution - Product Description
Table 12: ClearCorrect System - Product Status
Table 13: ClearCorrect System - Product Description
Table 14: ClearQuartz - Product Status
Table 15: ClearQuartz - Product Description
Table 16: ClearQuartz - Randomized Controlled Study to Assess Performance of Two Clearcorrect Clear Aligner Staging Schedules Using Digital Par Scores
Table 17: Colored Prosthetics - Product Status
Table 18: Colored Prosthetics - Product Description
Table 19: Enhanced Bone Graft - Product Status
Table 20: Enhanced Bone Graft - Product Description
Table 21: Grand Morse System - Product Status
Table 22: Grand Morse System - Product Description
Table 23: Grand Morse System - Clinical Performance of Dental Implants with Hydrophilic or Hydrophobic Surfaces in Single Posterior Edentulous Spaces: A Randomized Clinical Trial
Table 24: Grand Morse System - Incisors Single-unit Rehabilitation with Narrow GM Implants: Observational Prospective Study
Table 25: Integrated Workflow - Product Status
Table 26: Integrated Workflow - Product Description
Table 27: Neodent Zi - Product Status
Table 28: Neodent Zi - Product Description
Table 29: Next Generation Biomaterials - Product Status
Table 30: Next Generation Biomaterials - Product Description
Table 31: Next Generation Fixture System - Product Status
Table 32: Next Generation Fixture System - Product Description
Table 33: NUVO IF Implant System - Product Status
Table 34: NUVO IF Implant System - Product Description
Table 35: NUVO IF Implant System - Mandibular Full-arch Rehabilitation with Internal Hexagonal and Conical Connection Implants: Randomized Split-mouth Clinical Trial
Table 36: NUVO Instrument Kit Case - Product Status
Table 37: NUVO Instrument Kit Case - Product Description
Table 38: Single-Use Instrument - Product Status
Table 39: Single-Use Instrument - Product Description
Table 40: Soft Tissue Control Implant - Product Status
Table 41: Soft Tissue Control Implant - Product Description
Table 42: Straumann TLX Implant System - Product Status
Table 43: Straumann TLX Implant System - Product Description
Table 44: Variobase Extensions - Product Status
Table 45: Variobase Extensions - Product Description
Table 46: Virtuo Harmony - Product Status
Table 47: Virtuo Harmony - Product Description
Table 48: Straumann Holding AG, Key Employees
Table 49: Straumann Holding AG, Key Employee Biographies
Table 50: Straumann Holding AG, Subsidiaries
Table 51: Glossary
List of Figures
Figure 1: Straumann Holding AG Pipeline Products by Equipment Type
Figure 2: Straumann Holding AG Pipeline Products by Development Stage
Figure 3: Straumann Holding AG Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings